Cellular and molecular basis of wound healing in diabetes.

Diabetic foot ulcers (DFUs), a leading cause of amputations, affect 15% of people with diabetes. A series of multiple mechanisms, including decreased cell and growth factor response, lead to diminished peripheral blood flow and decreased local angiogenesis, all of which can contribute to lack of healing in persons with DFUs. In this issue of the JCI, Gallagher and colleagues demonstrate that in diabetic mice, hyperoxia enhances the mobilization of circulating endothelial progenitor cells (EPCs) from the bone marrow to the peripheral circulation (see the related article beginning on page 1249). Local injection of the chemokine stromal cell-derived factor-1alpha then recruits these EPCs to the cutaneous wound site, resulting in accelerated wound healing. Thus, Gallagher et al. have identified novel potential targets for therapeutic intervention in diabetic wound healing.

[1]  Jun Asai,et al.  Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. , 2007, The American journal of pathology.

[2]  R. Kirsner,et al.  Clinical practice. Neuropathic diabetic foot ulcers. , 2004, The New England journal of medicine.

[3]  V. Falanga,et al.  Debridement performance index and its correlation with complete closure of diabetic foot ulcers , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[4]  J. Fallon,et al.  Molecular pathogenesis of chronic wounds: the role of beta-catenin and c-myc in the inhibition of epithelialization and wound healing. , 2005, The American journal of pathology.

[5]  G. Reiber,et al.  Lower extremity foot ulcers and amputations in diabetes , 1995 .

[6]  J. Pfeilschifter,et al.  Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. , 2006, The American journal of pathology.

[7]  P. Kranke,et al.  Hyperbaric oxygen therapy for chronic wounds. , 2004, The Cochrane database of systematic reviews.

[8]  Cindy Farquhar,et al.  3 The Cochrane Library , 1996 .

[9]  F. Agani,et al.  Effects of Hyperoxia on Nitric Oxide Synthase Expression, Nitric Oxide Activity, and Lung Injury in Rat Pups , 1999, Pediatric Research.

[10]  D. Steed,et al.  Effect of extensive debridement and treatment on the healing of diabetic foot ulcers. Diabetic Ulcer Study Group. , 1996, Journal of the American College of Surgeons.

[11]  DOUGLAS G. Smith,et al.  Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. , 2002, The Journal of surgical research.

[12]  P. Kranke,et al.  Hyperbaric oxygen for chronic wounds , 2002 .

[13]  Geoffrey C Gurtner,et al.  Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. , 2004, The American journal of pathology.

[14]  J. Smiell.  Clinical safety of becaplermin (rhPDGF-BB) gel. Becaplermin Studies Group. , 1998, American journal of surgery.

[15]  A. Boulton,et al.  The global burden of diabetic foot disease , 2005, The Lancet.

[16]  Olivera Stojadinovic,et al.  Molecular Markers in Patients with Chronic Wounds to Guide Surgical Debridement , 2007, Molecular medicine.

[17]  W. Marston,et al.  The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. , 2003, Diabetes care.

[18]  Vincent Falanga,et al.  Wound healing and its impairment in the diabetic foot , 2005, The Lancet.

[19]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[20]  J. Smiell.  Clinical safety of becaplermin (rhPDGF-BB) gel , 1998 .

[21]  D G Smith,et al.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. , 1999, Diabetes care.

[22]  D. Buerk,et al.  Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. , 2007, The Journal of clinical investigation.

[23]  A. Boulton,et al.  Evidence-Based Protocol for Diabetic Foot Ulcers , 2006, Plastic and reconstructive surgery.

[24]  Andrew J.M. Boulton,et al.  Neuropathic Diabetic Foot Ulcers , 2004 .

[25]  W. Olszewski,et al.  Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers , 2006, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[26]  H. Brem,et al.  Healing of diabetic foot ulcers and pressure ulcers with human skin equivalent: a new paradigm in wound healing. , 2000, Archives of surgery.

[27]  H. Lehnert,et al.  Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients , 2002, Diabetologia.